The store will not work correctly when cookies are disabled.
We use cookies to make your experience better.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies.Learn more.
Just add 12 or more to your basket for discount to apply.
VISUfly soluble sachets for vitreous floaters (myodesopsia)
VISUfly contains key ingredients that support those suffering from vitreous floaters (myodesopsia). This includes bromelain, ficain, papain, peptan collagen, reduced glutathione, L-lysine and vitamin C (that helps protect cells against oxidative stress) as well as an added sweetener.
VISUfly is a dietary supplement designed to help protect cells against oxidative stress. It contains a specific complex of active ingredients including fruit enzymes and collagen.
Support cellular protection from oxidative stress
Promote collagen health for skin, joints, and connective tissues
VISUfly is presented in an easy-to-take daily sachet
Dissolve 1 sachet of VISUfly in a large glass of water, preferably at breakfast, and enjoy a refreshing orange-flavoured boost for your day.
*Add 12 or more to your basket for discount to apply. Promotion applies to standard list pricing only. Not valid in combination with any other pricing adjustments or promotional offers.
Bromelain: one of the most popular fruit enzymes, extracted from the pineapple stem and fruit, with hydrolytic and proteolytic properties.Ficain: a fruit enzyme produced by fig latex (Ficus carica). It has a proteolytic activity often used for the solubilisation of substances such as elastin, collagen, and various fibres. Papain: a proteolytic enzyme extracted from the latex of the raw fruit of the papaya plant. It has a hydrolytic action that promotes the breakdown of larger proteins into smaller fragments called peptides and amino acids. Glutathione: an endogenous powerful antioxidant. Peptan Collagen: a patented hydrolysed bovine collagen essential for the body, naturally present in mammals, that tends to decrease physiologically from as early as age 25.